Patents by Inventor John Bullock

John Bullock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR A SAMPLE FLUID COLLECTION DEVICE
    Publication number: 20080264151
    Abstract: A fluid collection device comprising a body comprising a capsule interface, and a capsule configured to interface with the body via the capsule interface and configured to hold a sample receiving chip. The sample receiving chip comprises a substrate that receives an aliquot volume of a sample fluid, wherein the substrate is operatively shaped to receive the aliquot volume of sample fluid through capillary action, and a sample region of the substrate, sized such that the volume of the sample fluid is sufficient to operatively cover a portion of the sample region, whereupon energy properties of the sample fluid can be transduced to produce a sample fluid reading.
    Type: Application
    Filed: March 28, 2008
    Publication date: October 30, 2008
    Applicant: OcuSense, Inc.
    Inventors: Benjamin Sullivan, Steve Zmina, Eric Donsky, Sasha Miu, Graeme John Bullock, Adam Ernest Donath, Fred Harry Davis, Andreas Knaack, Matthew Daniel Solomon, Erol Craig Harvey, Carl Gang Chen
  • In vitro methods for evaluating the in vivo effectivness of dosage forms of microparticulate or nanoparticulate active agent compositions
    Publication number: 20070110776
    Abstract: Disclosed are in vitro methods for evaluating the in vivo redispersibility of dosage forms of poorly water-soluble active agents. The methods utilize media representative of in vivo human physiological conditions.
    Type: Application
    Filed: January 8, 2007
    Publication date: May 17, 2007
    Inventors: Eugene Cooper, John Bullock, John Chippari, John Schaefer, Rakesh Patel, Rajeev Jain, Joost Strasters, Niels Ryde, Stephen Ruddy
  • methods for evaluating the effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
    Patent number: 7198795
    Abstract: Disclosed are in vitro methods for evaluating the in vivo redispersibility of dosage forms of poorly water-soluble active agents. The methods utilize media representative of in vivo human physiological conditions.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: April 3, 2007
    Assignee: Elan Pharma International Ltd.
    Inventors: Eugene R. Cooper, John A. Bullock, John R. Chippari, John L. Schaefer, Rakesh A. Patel, Rajeev Jain, Joost Strasters, Niels P. Ryde, Stephen B. Ruddy
  • Emergency medical treatment system
    Publication number: 20060207911
    Abstract: An medical treatment system in the form of a container for a solid wafer drug dose of a size which will fit into a billfold or wallet having solid wafer drug dose therein for use in emergencies or treatment of the container may be approximately credit-card-sized and may be disposable or reusable.
    Type: Application
    Filed: March 9, 2006
    Publication date: September 21, 2006
    Inventor: John Bullock
  • Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
    Publication number: 20040029099
    Abstract: Disclosed are in vitro methods for evaluating the in vivo redispersibility of dosage forms of poorly water-soluble active agents. The methods utilize media representative of in vivo human physiological conditions.
    Type: Application
    Filed: December 20, 2002
    Publication date: February 12, 2004
    Applicant: Elan Pharma International Ltd.
    Inventors: Eugene R. Cooper, John A. Bullock, John R. Chippari, John L. Schaefer, Rakesh A. Patel, Rajeev Jain, Joost Strasters, Niels P. Ryde, Stephen B. Ruddy
  • Opaque shielding element for liquid crystal display
    Publication number: 20020196398
    Abstract: LCDs for use in high intensity applications such as digital projectors are susceptible to performance degradation resulting from unwanted photoconductive effects that result from scattered light. Furthermore, the constraints under which these devices operate require that their TFTs be made of polysilicon. The present inventions shows how these problems can be overcome by inserting an opaque optical shielding element between the TFT active layer and the lower transparent plate of the LCD. Materials suitable for use in the shielding layer include thermally deposited silicon nitride, layers of silicon oxide and silicon nitride, and a refractory metal encapsulated in a suitable barrier layer.
    Type: Application
    Filed: July 5, 2001
    Publication date: December 26, 2002
    Applicant: European Semiconductor Manufacturing Limited
    Inventors: David Paul Jones, Richard John Bullock